| Objective To observe the effects of new Xuefu zhuyu soft capsule on the Signsof Blood Stasis and the levels of VEGF and bFGF in the Coronary Heart Disease.Method80cases of CHD were randomly divided in to a treatment group and acontrol group40cases in each one. In control group, the conventional westernmedicine was applied. In treatment group, on the basis of the treatment ascontrol group, the modified xuefu zhuyu capsule was added. The medication wasadministered for four weeks in two groups. Before and after treatment the signso f blood stasis were observed and levels were determined in two groups. ResultAfter treatment, the signs of blood stasis were relieved in either group, Thetotal effective rate in treatment group is obviously higher than that incontrol group.After treatment,the level of VEGF and bFGF in both groups wereobviously higher than before (P <0.05); compared with the control group aftertaking medicine, the treatment group after taking medicine has a obvioushigher level of VEGF and bFGF (P <0.05). Conclusion New Xuefu zhuyu softcapsule can relieves the signs o f blood stasis and elevate the levels of serumVEGF, bFGF, facilitating the building of the subordinate circulatory systemof coronary. It can improve the lack of oxygen in the cardiacmuscle in orderto cure coronary heart disease. |
PDF Full Text Request